["{\n\"step_by_step_thinking\": \"The patient is a 20-year-old man with worsening gait unsteadiness, bilateral hearing loss, and intermittent tingling sensations on both cheeks. The genetic evaluation shows a mutation of a tumor suppressor gene on chromosome 22 that encodes merlin. This suggests that the patient may have neurofibromatosis type 2 (NF2). According to the provided documents, NF2 is characterized by vestibulo-cochlear dysfunction, hearing loss, and other symptoms. Additionally, the document 'Dominant hereditary nerve deafness' suggests that the basic site of the lesion may be in the vascular system, which is consistent with the diagnosis of NF2. Therefore, the patient is at increased risk for developing Meningioma.\",\n\"answer_choice\": B"]